Pulmonary Regurgitation
📧 Sign up to get email alerts when something new happens for Pulmonary Regurgitation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Berlin Registry of Right Heart Interventions
This is a clinical trial registry update for the Berlin Registry of Right Heart Interventions. The study lists Tricuspid Regurgitation and P…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: ALTERRA Post-Approval Study
ALTERRA post-approval study by Edwards Lifesciences is currently ACTIVE_NOT_RECRUITING, focusing on pulmonary valve-related conditions and c…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial [Phase 4]
A Phase 4 clinical trial sponsored by The University of Hong Kong is evaluating the SGLT2 inhibitor dapagliflozin (Forxiga) to improve cardi…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: VenusP-Valve Pivotal Study (PROTEUS STUDY) [NA]
The VenusP-Valve pivotal PROTEUS study for treating pulmonary regurgitation is currently recruiting.
-
CLINICAL_TRIALS research · 2023-08-08Clinical Trial Update: ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent [NA]
Update on the ALTERRA trial evaluating the SAPIEN 3 transcatheter heart valve with the Alterra Adaptive Prestent for pulmonary valve procedu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.